Target intelligence / Profile preview

TCERG1 pseudogene 2 (TCERG1P2)

Target
TCERG1P2
Molecular classification
Other (pseudogene)
01

Overview

TCERG1 pseudogene 2 (TCERG1P2) is a genomic pseudogene resembling TCERG1, a protein involved in regulation of transcription elongation and alternative splicing[2][3]. Unlike the functional TCERG1, TCERG1P2 is not believed to encode a functional protein and has no demonstrated role in cellular biology or disease. Most scientific and medical resources refer to TCERG1 for molecular function, therapeutic relevance, and published disease links, but TCERG1P2 itself remains unmapped as a target for therapies or diagnostics.

Other names
TCERG1P2TCERG1 pseudogene 2

Beyond the preview

Go deeper on TCERG1 pseudogene 2 (TCERG1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCERG1 pseudogene 2 (TCERG1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call